Injective
INJ
Evaluation Score
Overall rating on a scale of 0-10
Crypto Token Health Score Explained
Our AI-powered health score evaluates on-chain metrics, community support, tokenomics, and more. This helps DeFi investors understand risk, compare tokens, and make informed decisions. Learn how to analyze DeFi tokens' risk and use these insights for DeFi portfolio risk management.
AI Analysis
Comprehensive evaluation of the token
Injective (INJ) Overall Evaluation
Injective is a well-established Layer-1 DEX and derivatives protocol built on Cosmos SDK, offering:
- Robust Development & Security: Active GitHub contribution (8/10) with fast PR reviews, rigorous CI/testing, multiple third-party audits (CertiK, PeckShield), formal verification, and no known exploits (9/10).
- Strong Community & Governance: Healthy organic engagement across Twitter, Discord, Telegram and a transparent on-chain governance process with >80% proposal pass rates (Community 8/10; Team & Governance 8/10).
- Balanced Tokenomics: Deflationary fee burns offsetting initial ~9.7% inflation, well-structured vesting (team/investors 4-year cliffs), and active staking mechanisms (8/10).
- Market Position & Use Case: Differentiated cross-chain derivatives offering with order-book matching, sub-second settlement, and partnerships (Chainlink, Binance) – but faces stiff competition from dYdX, Perp Protocol, Serum (Market 7/10).
Overall, INJ boasts a mature codebase, engaged community, clear utility, and sound security, yet must navigate competitive pressures and moderate governance centralization.
Detailed Analysis by Category
Development Activity
Code updates and developer engagement
Community Support
Social media presence and community engagement
Tokenomics
Supply, distribution, and utility
Market & Use Case
Value proposition and competitive landscape
Team & Governance
Team background and project governance
Security & Audits
Security history and audit status
About Injective (INJ)
Injective (INJ)
Injective is a decentralized layer-2 blockchain protocol designed to bring advanced financial products and trading to DeFi. Powered by the INJ token, Injective delivers cross-chain interoperability, high-speed transactions, and a fully on-chain order book.
Key Features
- Symbol: INJ
- Token Type: Native utility and governance token
- Consensus: Proof-of-Stake with Tendermint
- Interoperability: Cosmos IBC and Ethereum (Peggy bridge)
- Transaction Fees: Zero gas fees for trading on Injective dApps
Core Use Cases
- Governance: Propose and vote on protocol upgrades and parameter changes
- Staking: Delegate INJ to validators to secure the network and earn rewards
- Transaction Fees: Settle trading and order fees within the Injective ecosystem
- Incentives: Participate in liquidity mining and ecosystem growth programs
Technology Stack
- Cosmos SDK–based layer-2 network
- Ethereum Virtual Machine (EVM)–compatible environment
- On-chain order book for spot and derivatives markets
- High throughput with fast finality
Resources
- Website: https://injective.com/
- Documentation & Whitepaper: https://docs.injective.com/
- Community: Twitter / Telegram / Discord
Similar Rated Tokens
Jupiter Perpetuals Liquidity Provider Token
JLP
Mantle
MNT
VeChain
VET
Ankr Network
ANKR
Wormhole
W
Aavegotchi
GHST
Liquity
LQTY
Bancor Network
BNT
More for DeFi Investors
- Yield Farming Analysis: Discover the best tools and strategies for maximizing your returns from yield farming in DeFi.
- AI vs Fundamentals: See how Token Vitals combines AI crypto price prediction with fundamental analysis for a balanced investment perspective.
- Risk Scores Explained: Learn how our crypto risk scores differ from traditional credit scores and what that means for your portfolio.
- On-Chain Metrics: Understand which on-chain metrics matter most when investing in tokens and how to use them effectively.
- US Investor Analytics: Access crypto analytics designed for US investors, including features to help with tax tracking and compliance.
- Finding Value: Explore our data-driven lists to uncover top undervalued DeFi tokens for 2025 and beyond.